Construction and application of prerehabilitation program for patients undergoing surgery for pancreatic cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056214

Enrollment

Unknown

Registered

2022-02-01

Start date

2022-02-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancratic cancer

Interventions

Prehabilitation group:Triple prehabilitation mode

Control group:Routine preoperative intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years old; 2. Pancreatic cancer was expected to be diagnosed in the hepatobiliary surgery clinic; 3. Elective pancreatic surgery is expected; 4. The informed consent is signed.

Exclusion criteria

Exclusion criteria: 1. ASA grade III or above; 2. Unable to work with others (mental disorder, consciousness disorder, intelligence disorder); 3. Unable to tolerate family rehabilitation training or functional motor test complications; 4. Severe liver and kidney insufficiency or intolerance to whey protein powder; 5. Pregnant or lactating women; 6. Currently participating in other interventional clinical trials.

Design outcomes

Primary

Measure	Time frame
Six Minute Walk Distance (6MWD);	—

Secondary

Measure	Time frame
Postoperative complications;Hospitalization expenses;LOS(length of stay);HADS;Length of stay in ICU;Chest drainage condition;	—

Countries

China

Contacts

Public ContactYanshuang Cheng

PLA General Hospital

1597495162@qq.com+86 13661216729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026